Key result
Preconditioning of mesenchymal stem cells with SDF-1 enhanced cell survival, proliferation, and engraftment, reduced infarct size, and improved cardiac function in infarcted myocardium.
Why the study?
Does preconditioning mesenchymal stem cells with SDF-1 improve cell survival, engraftment, and cardiac function in a rat model of myocardial infarction?
Does preconditioning mesenchymal stem cells with SDF-1 improve cell survival, engraftment, and cardiac function in a rat model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
Preconditioning mesenchymal stem cells with SDF-1 enhances their survival and engraftment, leading to improved myocardial function and reduced infarct size in a rat model of myocardial infarction.
AIMS: We hypothesized that preconditioning (PC) with stromal-derived factor 1 alpha (SDF-1) significantly enhances cell survival, proliferation, and engraftment of bone marrow-derived mesenchymal stem cells (MSCs) via SDF-1/CXCR4 signaling. METHODS AND RESULTS: MSCs were cultured and then incubated in medium for 60 min without SDF-1 (control group) or with SDF-1 0.05 microg/mL (SDF-1 group) or CXCR4-selective antagonist, AMD 3100 (AMD) (5 microg/mL, AMD group) or SDF-1 and AMD (0.05 microg/mL, 5 microg/mL, respectively, SDF-1+AMD group). MSCs were treated for 60 min, washed in normal medium, and then exposed to H2O2 (100 micromol/L) for 60 min to determine the effects of various treatments on cell injury, viability, and proliferation. For in vivo studies, rats were grouped (n = 6) after left anterior descending coronary artery ligation to receive 20 microL Dulbecco's modified Eagle's medium without cells or with 5 x 10(5) non-preconditioned MSCs (control group), SDF-1 preconditioned MSCs (SDF-1 group), AMD (AMD group), or MSCs treated with SDF-1 plus AMD (SDF-1+AMD group). Heart function, infarct size, fibrosis, and MSC proliferation and differentiation in infarcted myocardium were determined after 4 weeks. In vitro data showed a marked increase in cell viability and proliferation following SDF-1 PC. In vivo data in preconditioned group showed a robust cell proliferation, reduction in infarct size and fibrosis, and significant improvement in cardiac function. Effects of SDF-1 PC were abrogated by CXCR4 antagonist. CONCLUSION: We conclude that PC with the chemokine SDF-1 suppresses MSCs apoptosis, enhances their survival, engraftment, and vascular density, and improves myocardial function via SDF/CXCR4 signaling. Chemokine PC is a novel approach for enhancing stem cell survival and regeneration of infarcted myocardium.
No takes yet. Share an insight, caveat, or question.
Pasha et al. (2007) studied Infarcted myocardium. Preconditioning with stromal-derived factor 1 alpha (SDF-1) vs. Non-preconditioned MSCs (control group) was evaluated on Cell survival, proliferation, infarct size, fibrosis, and cardiac function. Preconditioning of mesenchymal stem cells with SDF-1 enhanced cell survival, proliferation, and engraftment, reduced infarct size, and improved cardiac function in infarcted myocardium.
Synapse has enriched 10 related papers. Consider them for comparative context: